1
|
OMEPRAZOL. EN : 01 UNIDAD DE OMEPRAZOL (ESTANDAR PRIMARIO)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-27
|
FRANCE
|
0.06 Kgs
|
0.01 0
|
2
|
LOS DEMAS EN : 01 UNIDAD DE MOEXIPRIL COMPUESTO F (ESTANDAR PRIMARIO)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-27
|
CANADA
|
0.05 Kgs
|
0.02 0
|
3
|
LOS DEMAS EN : 01 UNIDAD DE IVERMECTINA (ESTANDAR PRIMARIO)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-27
|
MACAO
|
0.05 Kgs
|
0.01 0
|
4
|
FINASTERIDE (200 MG)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-26
|
ITALY
|
0.33 Kgs
|
0.33 0
|
5
|
ROSUVASTATIN SYSTEM SUITABILITY MIXTURE (15 MG) (A MIXTURE CONTAINING ROSUVASTATIN CALCIUM, ROSUVASTATIN KETONE, ROSUVASTATIN LACTONE AND ROSUVASTATIN DIASTEREOMERS.)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-26
|
INDIA
|
0.01 Kgs
|
0.01 0
|
6
|
ACETAMINOPHEN RELATED COMPOUND F (50 MG) (P-NITROPHENOL)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-26
|
JAPAN
|
0.01 Kgs
|
0.01 0
|
7
|
CYANOCOBALAMIN (CRYSTALLINE) (2 X 150 MG)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-26
|
CHINA
|
0.01 Kgs
|
0.01 0
|
8
|
QUETIAPINE SYSTEM SUITABILITY (25 MG) (MIXTURE CONTAINS QUETIAPINE FUMARATE AND ABOUT 1% EACH OF QUETIAPINE RELATED COMPOUND B, QUETIAPINE RELATED COMPOUND G ANDQUETIAPINE DESETHOXY)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-26
|
INDIA
|
0.01 Kgs
|
0.01 0
|
9
|
FEXOFENADINE RELATED COMPOUND C (25 MG) (4-[4-(HYDROXYDIPHENYLMETHYL)PIPERIDIN-1-YL]-1-(4-ISOPROPYLPHENYL)BUTAN-1-OL HYDROCHLORIDE)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-26
|
CZECH REPUBLIC
|
0.01 Kgs
|
0.01 0
|
10
|
FEXOFENADINE RELATED COMPOUND B (25 MG) (2-(3-{1-HYDROXY- 4-[4-(HYDROXYDIPHENYLMETHYL)PIPERIDIN-1-YL]BUTYL}PHENYL)-2-METHYLPROPANOIC ACID HYDROCHLORIDE MONOHYDRATE)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
USP CONVENTION
|
2025-03-26
|
INDIA
|
0.01 Kgs
|
0.01 0
|